SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-18-009907
Filing Date
2018-02-21
Accepted
2018-02-21 08:04:12
Documents
3
Group Members
BLUE MAGPIE CORP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv486593_sc13da.htm SC 13D/A 70242
2 EXHIBIT (A)(5)(K) tv486593_ex99-a5k.htm EX-99.(A)(5)(K) 10336
3 GRAPHIC image_001.jpg GRAPHIC 9488
  Complete submission text file 0001144204-18-009907.txt   95348
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filed by) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109
Business Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Subject) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88476 | Film No.: 18627093
SIC: 2836 Biological Products, (No Diagnostic Substances)